Global Amniocentesis Needle Market is valued at USD 172.01 Million (€ 139.92 Mn) in 2020 and expected to reach USD 226.23 Million (€ 184.02 Mn) by 2027 with the CAGR of 3.97 % over the forecast period.
Scope of the report
This report analyses the global market for Amniocentesis Needle. The report will enable the user to understand and gain insights into the current and forecast market situation. The market is comprehensively analyzed by geography to give complete information on the global scenario. The qualitative and quantitative data provided in this study can help user understand which market segments, regions are expected to grow at higher rates, factors affecting the market and key opportunity areas. The report also includes competitive landscape of key players in the industry along with emerging trends in the market.
Amniocentesis needles are used in amniocentesis procedures. Amniocentesis is an invasive procedure in which a sample of fetal exfoliated cells, transudates, urine samples are removed from the uterus for testing or treatment. This procedure is performed after 4 months of pregnancy to do a variety of tests such as genetic testing, fetal lung testing, paternity testing, treatment diagnosis of fetal infection.
In the last few years numbers of amniocentesis procedures have increased significantly due to rise in awareness regarding the benefits of amniocentesis procedures in prenatal disease and defect detection. Globally more than 7.9 million infants around 6% of the world are born with serious birth defects. Growing advancements in the procedure, rising numbers of congenital disorders are offering several growth opportunities for the market in the forecast period 2020-2027.
- Tsunami Medical
- Smiths Group Plc
- Rocket Medical Plc
- Medtronic Plc
- Integra Lifesciences Holdings Corporation
- CooperSurgical Inc.
- Cook Medical Inc.
- Cardinal Health
- Becton Dickinson and Company
Above mentioned companies were scrutinized to assess competitive landscape of global Amniocentesis Needle market. Report provides company profiles of each player. Each profile include company product portfolio,business overview, company governance, company financials, business strategies, manufacturing locations and production facilities, company sale, recent developments and strategic collaborations & partnerships, new product launch, company segments, application diversification and company strength and weakness analysis.
Growing technological advancements in medical devices are transforming amnioreduction needles to provide better test samples and insertion with no needle stick injury. Several players in the market are focusing on product development to offer low cost robust needles made up of strong materials as there are several cases of needle deflections during the biopsy procedure. Moreover companies are also engaging in significant acquisitions, mergers, collaborations, and strategic partnerships to lift their growth. For instance in November 2017, Merit Medical Systems, Inc. has acquired Becton, Dickinson and Company’s soft tissue core needle biopsy products, which comprise a temno biopsy system, achieve programmable automatic biopsy system, and tru-cut biopsy needles.
Review period: (2016-2027)
Historic Period: 2016 to 2020
Forecast Period: 2021 to 2027
Base Year: 2020
Unit: USD Million
This Amniocentesis Needle market report provides insights on new trade regulations, import export analysis, industry value chain analysis, market size, consumption, production analysis, regional and segment market share, product launches, product pipeline analysis, impact of Covid-19 on supply chain, key regions, untapped markets, patent analysis, product approvals, continuous innovations and developments in the market.
- North America: U.S., Canada and Rest of North America
- Europe: UK, France, Germany, Italy, Spain and Rest of Europe
- Asia Pacific: China, Japan, India, Australia, Southeast Asia and Rest of Asia Pacific
- Latin America: Brazil, Mexico, Argentina and Rest of Latin America
- Middle East and Africa: Gulf Countries, Israel, Africa and Rest of Middle East and Africa
By geography North America dominates the global amniocentesis needle market. The region has one of the world’s advanced healthcare systems with best health care professionals. The U.S. leads the market accounting for the largest revenue share in 2019. According to CDC estimates one in every 33 babies about 3% is born in the United States is affected by a birth defect every year. Birth defects are responsible for more than 20% deaths in the country.
Europe was second in terms of revenue generation followed by Asia Pacific in the year 2019. The rate of prenatal screening in the region has increased rapidly since last few years. Rising disposable income, good healthcare and diagnostic facilities, and an increasing number of birth defects are accelerating the growth of European market. Countries like Italy, Spain, Austria, the Netherlands and Belgium are leading the market in the region with the highest number of tests performed.
Asia Pacific is expected to witness the fastest growth in the forecast period owing to rising awareness regarding the use of amniocentesis procedure and the massive potential in the maternal health. Growing prevalence of birth defects in newborns, developing healthcare sector in developing countries, rising disposable income will fuel the product demand in the region. The Asia Pacific market is primarily driven by rapidly developing economies such as China, India and other South Asian countries. Each year in South Asia about one million babies are stillborn which is nearly 37 percent of world stillbirths is and the number is expected to increase in the future years due to the presence of poor healthcare facilities.
o 100 to 150 mm Needles
o Larger Than 150 mm Needles
o Smaller Than 100 mm Needles
o Amniocentesis Procedures
o Amnioreduction Procedures
o Fetal Blood Transfusion Procedures
o Amnioinfusion Procedures
o Cordocentesis Procedures
• End User
o Diagnostic Centers
On the basis of procedure segment market is segmented into Amniocentesis Procedures, Cordocentesis Procedures Fetal Blood Transfusion Procedures, Amnioreduction Procedures and Amnioinfusion Procedures. Amniocentesis procedure segment accounted for the largest revenue in the year 2019 and is expected to lead the market in the forecast period 2021-2027.
Hospital was the leading end user segment in terms of revenue generation in the year 2019. Most amniocentesis procedures are performed in hospitals as recommended by doctors as per severity and necessity. The rising awareness regarding the procedure, increase in frequency of tests and developing hospital infrastructure around the world is expected to boost the growth of the hospital segment in the forecast period. The Diagnostic Centers segment is witnessing strong growth in the last few years; several private diagnostic centers are offering the amnioreduction procedures tests at affordable price ranges. Several hospital chains, private organizations are entering into the diagnostic market which has increased the number of diagnostic facilities with better infrastructure and tools for different procedures.
On the basis of type segment market is segmented into 100 to 150 mm needles, larger than 150 mm needles and smaller than 100 mm needles. The 100 to 150 mm needles segment accounts for the largest market revenue share in the year 2019. 100 to 150 mm needles are extensively used in the amniocentesis procedures due to their
• An overview of the global Amniocentesis Needle market
• In depth analysis of market dynamics and major factors such as drivers, restraints, opportunities and trends influencing the global market
• Global Amniocentesis Needle market revenue data historic and forecast analysis (2016 to 2027)
• Characterization and quantification of the market segments for Amniocentesis Needle market
• Market share analysis of key market participants and their competitive landscape
Important Questions Answered by Global Amniocentesis Needle Market Report
• What is the impact of COVID 19 epidemic on the global Amniocentesis Needle market?
• Which is mostly affected region, country?
• Which is the current largest and fastest-growing region?
• What is the market size and growth rate of the global Amniocentesis Needle market?
• What are current factors affecting the growth of market?
• What are Key trends and opportunity areas?
• Within Amniocentesis Needle market, which segments are fastest growing & emerging strongly? What are the drivers and restraints for each segment? What are vendor competencies by segment?
• What are the major strategies adopted by leading market companies?
• What are company challenges and essential success factors by market segment?
• How company offerings and supply chain capabilities are shifting to meet emerging market needs?